Enzyme Engineering

& Industrial Fermentation

Enzymes are widely used as biocatalysts in the production or processing of a wide range of products including food, beverages, animal feeds, detergents, pharmaceuticals and textile products. Naturally occurring enzymes are often unstable or perform sub-optimally when moved from the biological to the industrial sphere.

Therefore, since the advent of protein engineering there have been efforts to improve these enzyme properties, and even to devise enzymes with novel specificities capable of producing types or quantities of metabolites not normally achievable in natural products. Such improvements or changes can often be challenging: enzyme activity depends on specific and highly complex structures, sometimes formed from multiple protein components, and requiring associated factors or metal ions to operate. Frequently, enhancing one desirable property comes at the cost of impairing another.

Mewburn Ellis has a long history of working with our clients in this fast-moving and competitive field. For example, we’ve been involved in protecting the ground-breaking innovations on the serine protease subtilisin (used for example in detergents and in food processing) since 1980s, and in multiple other enzymes in different fields such as brewing, biofuels and biopolymers. The Mewburn team has regularly and successfully defended patents covering our clients’ enzyme technologies at the EPO and assisted them in enforcing those patents before national courts. Engineered enzymes are typically produced in host species such as bacteria, yeasts and filamentous fungi and we also have many years’ experience in dealing with the fermentation technologies used for growing these microorganisms, and recovering the enzymes from them, whether at laboratory or industrial scale.

As more and more powerful computation tools are developed for determining and modelling protein structures, so protein engineers are increasingly able to analyse the structure-function characteristics for rationale design of novel enzymes, which can then be tested in large scale functional screening processes. Once again, our specialised team here is able to assist at our clients with obtaining protection for their intellectual property in the latest bioinformatics innovations in the enzyme space.

Open pages of Green IP Report

Green IP Report

Patents are both a driver and a barometer of innovation

Our report examines the role of patents in making innovative ‘green’ technologies into a reality as well as how the patent landscape can be used to identify opportunities for partnering, collaboration and investment.

We share our enthusiasm and admiration for commercially-focused innovation across a diverse range of technologies, from repurposing carbon dioxide to make protein-rich foods, to the multi-faceted approach to a circular plastics economy. We also discuss the tantalising prospect of AI-mediated renewable energy supply, and the harnessing of battery tech from the EV boom to drive energy efficiency in consumer devices. This report reflects our passion for technology solutions that tackle our shared global challenge.

Download the Report

Read our Blogs

UPC Weekly - Court of Appeal settles the UPC framework for inventive step

UPC Weekly - Court of Appeal settles the UPC framework for inventive step

by Matthew Naylor

2025 Week 48 If you only read one UPC decision this year, read one of these. You can take your pick, based on technical background. Amgen v. Sanofi / Regeneron is in the field of antibodies for ...

UPC Weekly - Same parties, same prior art, same patent – different claim interpretations in the UPC and UK lead to different outcomes

UPC Weekly - Same parties, same prior art, same patent – different claim interpretations in the UPC and UK lead to different outcomes

by Matthew Naylor

2025 Week 47 We don’t often get to see the same patent being assessed in an EPO opposition, in the UK Patents Court and also at the Unified Patent Court. So we’ve lucked out with Advanced Cell ...

UPC Weekly - Have a second iron in the fire – hedging PI risk against the same medical device

UPC Weekly - Have a second iron in the fire – hedging PI risk against the same medical device

by Matthew Naylor

2025 Week 46 The last month or so has seen a significant number of decisions on preliminary injunctions (PIs) for medical devices. What’s been noticeable about many of these cases is that they come ...

What does the UK Precision Breeding Act mean for Agriculture?

What does the UK Precision Breeding Act mean for Agriculture?

by Louise Atkins

British agriculture reached a significant milestone on 13 November 2025, when the Genetic Technology (Precision Breeding) Regulations 2025 officially came into effect. In combination with the Genetic ...

UPC Weekly - UPC Court of Appeal brings order to the galaxy

UPC Weekly - UPC Court of Appeal brings order to the galaxy

by Matthew Naylor

2025 Week 45 This week we report on two recent and important UPC Court of Appeal decisions. Each considers claim interpretation and the relevance of expert and experimental evidence to UPC ...

UPC Weekly - File wrapper bites at the UPC

UPC Weekly - File wrapper bites at the UPC

by Matthew Naylor

2025 Week 44 Claim interpretation at the UPC has been one of the most consistent threads through the decisions coming out of the first instance UPC courts, due in part to an early setting of the ...

Learn More
Forward Magazines Overlapping 8

Mewburn Ellis

FORWARD MAGAZINE

Mewburn Ellis Forward is a biannual publication that celebrates the best of innovation and exploration. Through its pages we hope to inform and entertain, but also to encourage discussion about the most compelling developments taking place in the scientific and entrepreneurial world. Along the way, we’ll engage with the IP challenges that international organisations face every day.